发明名称 |
Combination therapy comprising ribavirin and interferon alpha in antiviral treatment haive patients having g chronic hepatitis C infection |
摘要 |
Use of ribavirin and interferon alpha to prepare pharmaceutical compositions for treating antiviral treatment naive patient having chronic hepatitis C infection to eradicate detectable HCV-RNA involving a combination therapy using a therapeutically effective amount of ribavirin and a therapeutically effective amount of interferon-alpha for a time period of from 20 up to 50 weeks are disclosed. |
申请公布号 |
AU2005220271(A1) |
申请公布日期 |
2005.11.03 |
申请号 |
AU20050220271 |
申请日期 |
2005.10.10 |
申请人 |
SCHERING CORPORATION |
发明人 |
JANICE K ALBRECHT |
分类号 |
A61K31/70;A61K31/7056;A61K38/21;A61P1/16;A61P31/12;A61P31/14 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|